Re-Evaluation of Combinational Efficacy and Synergy of the Italian Protocol In Vitro: Are We Truly Optimizing Benefit or Permitting Unwanted Toxicity?

Introduction: Adrenocortical carcinoma (ACC) is a rare endocrine malignancy, with very poor prognosis as a majority of the patients have advanced disease at the time of diagnosis. Currently, adjuvant therapy for most patients consists of either mitotane (M) alone or in combination with multi-drug ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Subramanian, Chitra, McCallister, Reid, Kuszynski, Dawn, Cohen, Mark S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467159/
https://www.ncbi.nlm.nih.gov/pubmed/34572375
http://dx.doi.org/10.3390/biomedicines9091190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467159/
https://www.ncbi.nlm.nih.gov/pubmed/34572375
http://dx.doi.org/10.3390/biomedicines9091190

Ejemplares similares